The hottest medical soft bag has entered the fast

  • Detail

Pharmaceutical soft packaging has entered the fast lane of development

at present, almost all the top 100 global pharmaceutical enterprises have established joint ventures or wholly-owned pharmaceutical enterprises in China, which not only brings more new drug varieties, but also advanced pharmaceutical packaging concepts and standards. Standardization has undoubtedly become the development direction of China's pharmaceutical industry

in terms of quantity. Pharmaceutical flexible packaging is the second largest category after food flexible packaging, but in terms of profit margin, its "gold content" far exceeds that of food flexible packaging. Some experts predict that the next five years will be a critical period for the rapid development of China's pharmaceutical packaging industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, which can only meet about 80% of the needs of domestic pharmaceutical enterprises. According to the development speed of China's pharmaceutical industry in recent years, the annual GDP of pharmaceutical packaging materials will quickly exceed 20billion yuan in a short time. As a "new force" of Chinese pharmaceutical packaging materials, pharmaceutical flexible packaging has entered a period of rapid development driven by the rapid development of the pharmaceutical industry

OA is a lever

internal and external factors work together to promote the pharmaceutical flexible packaging

the reason why China's pharmaceutical flexible packaging market has today's "booming" is inseparable from the joint influence of internal and external factors. The so-called "internal cause" is the own characteristics of pharmaceutical flexible packaging. The rapid development of pharmaceutical flexible packaging is due to its obvious advantages. First of all, medical flexible packaging is rich in material selection, and the cost is relatively low. As the main materials of pharmaceutical flexible packaging, plastic, paper plastic and other composite materials show incomparable "three low" advantages of glass and metal, that is, low raw material prices, low transportation costs and low production costs. Secondly, the feeding, film making, printing, packaging and other processes in the production process can be completed at one time, which reduces the possible pollution of drugs caused by environmental and human factors and the impact on the drug production process, ensures the safety of drugs, and at the same time, it is easy to realize production automation and high production efficiency. Finally, due to the properties of flexible packaging materials, the drugs have good sealing and quality assurance after packaging, and have a long storage period, which can reach 3 ~ 5 years. It is not easy to be damaged during transportation and storage

"external cause" is the prosperity of the general environment of China's pharmaceutical market. Data show that by 2005, the demand for drugs in China will reach 218billion yuan, and by 2010, the total consumption of drugs in rural areas alone is expected to reach 40billion yuan. The growth of the total population, the aging of the population structure and the migration of rural population to cities will be the basic conditions for the steady growth of the domestic pharmaceutical market. At present, China has become the second largest producer of bulk drugs in the world, and antibiotics and vitamins have ranked among the best in the world. At the same time, China's pharmaceutical packaging is entering a "transition period" from old-fashioned packaging to new-type packaging, and the packaging requires innovation, which undoubtedly plays a role in promoting the development of pharmaceutical flexible packaging

the market highlights two patterns

at present, China's pharmaceutical enterprises are mainly distributed in Jiangsu, Zhejiang and Guangdong. In terms of quantity and scale, pharmaceutical enterprises in Guangdong and Jiangsu and Zhejiang dominate. It is reported that since China began to implement the registration system management of drug packaging materials in 2000, in more than three years, you can rest assured to know about the relevant information. In the information room, more than 740 varieties in the country have passed the review and registration of the former State Drug Administration, including more than 1O0 in Guangdong Province, ranking first in all provinces and cities

China's pharmaceutical flexible packaging production enterprises are also mainly concentrated in the above regions, and the market distribution forms two major patterns. One is the "giant" enterprise effect, represented by Lianyungang Zhongjin pharmaceutical packaging and Nanfang packaging. CICC pharmaceutical packaging is one of the earliest enterprises in China to produce and promote pharmaceutical PTP aluminum foil and SP composite film, and it is also the largest professional pharmaceutical packaging material manufacturer in China, with 4 GMP standards; Good manufacturer. At present, Nanfang packaging can produce 5000 tons of flexible packaging composite film every year, and the sales of drug packaging materials account for about 60%, nearly 150million yuan

the other is the intensive effect of "bases", such as Anbu in Guangdong, Xiongxian in Hebei, Jiangyin in in Jiangsu, Longgang in Zhejiang (the four are collectively referred to as "China's four major flexible packaging production bases"). In the early 1990s, some packaging and printing enterprises in Anbu found that drug packaging materials with a production process similar to that of food packaging materials had higher profits, so some enterprises took the lead in producing drug packaging materials, thus opening the prelude to the development of Anbu drug packaging industry. Anbu can now produce 5 series and 11 varieties of drug packaging materials based on flexible packaging composite film. Famous drug manufacturers such as Harbin Pharmaceutical No. 3 factory and Guizhou magic pharmaceutical factory have chosen Anbu's drug packaging material manufacturers as their partners, which has formed a "base" effect of pharmaceutical flexible packaging. The development goal of Anbu pharmaceutical packaging materials industry in the next three years is: the total number of pharmaceutical packaging materials production enterprises will reach about 50, further highlighting the clustering advantage: the GDP will exceed 600million yuan, accounting for more than 20% of the total value of the printing and packaging industry in the town

safety and convenience have become the mainstream of the development of medical soft bags

the role of medical supplies is to "heal the sick and save the people", so the requirements for safety are very high, from the purchase of raw materials, to production and processing, until the product leaves the factory, there are very strict standards; Good. At the same time, with the reform of China's medical system and the diversification of drug types, the forms of pharmaceutical soft packaging have also been diversified. In recent years, the packaging of solid drugs in China, such as plain tablets, capsules, injections and externally applied drugs, has been updated rapidly. At the same time, the use of disposable plastic syringes has brought a major change to the packaging and application of injections in China. At present, the widely used pharmaceutical soft packaging in the domestic market mainly includes pharmaceutical blister packaging, composite tear bags, infusion soft bags, SP composite bags, non PVC infusion bags and pharmaceutical composite hoses. Among them, infusion soft bag packaging products and blister packaging are one of the most used packaging forms in pharmaceutical soft packaging

infusion soft bag packaging has many incomparable advantages over glass bottle infusion. At present, 26 factories in China have introduced various plastic soft package infusion production lines. According to incomplete statistics, more than 20 factories have been actively investigating the soft plastic infusion market, technology and equipment at home and abroad recently, and are preparing to introduce new production equipment and technology this year and next. It is expected that the production and market of soft plastic infusion in China will develop steadily in the next 10 years

at present, PVC (polyvinyl chloride) is the most common polymer used to make films for intravenous injection bags. However, due to some defects in the safety performance of PVC, China encourages the production and use of advanced non PVC infusion soft bag packaging products. Non PVC infusion flexible packaging bags are fully enclosed intravenous infusion products with a new international concept. Developed countries have been in clinical application for more than ten years. China has also strengthened the management in this regard in recent years. The Interim Measures for the administration of containers of materials for pharmaceutical packaging I, which contains relevant contents, has been issued. At present, there are only 28 relevant production enterprises and 35 production lines in China, and the annual output is only 90million bags, which is far from the annual demand of nearly 3billion infusion bags clearly stated in ASTM d1894 specification

with the introduction of OTC (over-the-counter drugs) related policies, drugs have changed from a single hospital monopoly to market-oriented open sales. Convenience and beauty have become the driving factors to attract "consumers" to choose and buy, which also stimulates the pace of packaging upgrading. Industry insiders pointed out that in terms of the world trend of drug packaging, the mainstream packaging with 1 o0 capsules per bottle will gradually decline and be replaced by blister packaging. At present, China has obtained the production license of drug packaging materials, and manufacturers of blister packaging materials, including tablets, films aluminum foil There are more than 165 (composite) enterprises, with a considerable production scale. Because blister packaging is one of the most widely used and fastest-growing flexible packaging materials in the pharmaceutical industry today, and it is also the main packaging form of solid dosage forms of drugs in China at present, it has taken China nearly 20 years from the initial introduction of equipment, technology and raw materials to the self-sufficiency of its own manufacturing equipment and raw materials. With the rapid development of the packaging industry, people The requirements for the plastic film used for blister packaging of drugs are also very strict: it should be thin and barrier enough, but also easy to tear but not easy to crack and high transparency, so that the drugs can be seen at a glance. It is expected that the blister packaging of drugs in China will have a faster development by 2010

in the future, we should take the road of standardized development

compared with developed countries, there is still a certain gap in China's pharmaceutical flexible packaging, which restricts the rapid development of the pharmaceutical flexible packaging industry to some extent. At present, almost all the top 100 global pharmaceutical enterprises have established joint ventures or wholly-owned pharmaceutical enterprises in China, which not only brings more new drug varieties, but also advanced pharmaceutical packaging concepts and standards. "Standardization" has undoubtedly become the direction of the development of China's pharmaceutical industry. Pharmaceutical manufacturers have applied for "production quality management norms" (GMP) to improve product quality. With the in-depth implementation of GMP transformation in pharmaceutical factories, some backward production equipment that do not meet the requirements of drug production quality will be eliminated, and drug packaging is becoming more and more rigorous in material selection. The standardization of the pharmaceutical market will certainly drive the development of the pharmaceutical flexible packaging market in the direction of standardization. Pharmaceutical flexible packaging enterprises have requested to implement the GMP certification system in the pharmaceutical packaging material industry as soon as possible

with the improvement of the domestic pharmaceutical flexible packaging market, it is bound to participate in the competition in the international pharmaceutical flexible packaging market. Establishing and improving relevant standards in line with international standards can effectively avoid future trade disputes

in addition to the standardization of the system, according to the market demand, the pharmaceutical flexible packaging is more environmentally friendly and functional. Packaging materials 5, 6, 7, many times per shift) the transmission gear surface is coated with a little semi-rigid grease and the development of packaging technology is endless. Some traditional packaging materials and containers are replaced by new materials and containers, which is the inevitable result of technological development and market competition. In terms of the development of pharmaceutical flexible packaging, eight types of packaging, including green packaging, less metering packaging, environmental regulation packaging, serialized packaging, high barrier packaging, sterile packaging, antibacterial packaging and nano packaging, will show infinite "charm" in the future pharmaceutical flexible packaging market

information source: export commodity packaging

Copyright © 2011 JIN SHI